INVITRO ACTIVITY OF AMPICILLIN PLUS SULBACTAM AGAINST ANAEROBES COMPARED TO AMPICILLIN AND CEFOXITIN

被引:15
作者
HEIZMANN, W
HEILMANN, F
WERNER, H
机构
关键词
D O I
10.1007/BF01647747
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:370 / 374
页数:5
相关论文
共 13 条
[1]   SULFONE BETA-LACTAM COMPOUND WHICH ACTS AS A BETA-LACTAMASE INHIBITOR [J].
ASWAPOKEE, N ;
NEU, HC .
JOURNAL OF ANTIBIOTICS, 1978, 31 (12) :1238-1244
[2]   BETA-LACTAMASE INHIBITORS IN PERSPECTIVE [J].
BUSH, K ;
SYKES, RB .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1983, 11 (02) :97-107
[3]  
HAMMANN R, 1980, CURRENT CHEMOTHERAPY, P756
[4]  
JONES RN, 1983, 13TH P INT C CHEM VI
[5]   CONCENTRATIONS OF AMPICILLIN PLUS SULBACTAM IN SERUM AND INTESTINAL-MUCOSA AND EFFECTS ON THE COLONIC MICROFLORA IN PATIENTS UNDERGOING COLORECTAL SURGERY [J].
KAGER, L ;
MALMBORG, AS ;
SJOSTEDT, S ;
NORD, CE .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1983, 2 (06) :559-563
[6]  
RETSEMA JA, 1983, 13TH P INT C CHEM VI
[7]   COLLABORATIVE EVALUATION OF A PROPOSED REFERENCE DILUTION METHOD OF SUSCEPTIBILITY TESTING OF ANAEROBIC-BACTERIA [J].
SUTTER, VL ;
BARRY, AL ;
WILKINS, TD ;
ZABRANSKY, RJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1979, 16 (04) :495-502
[9]  
WERNER H, 1985, FORTSCHR ANTIMIKR AN, V4, pS1293
[10]  
WERNER H, 1986, THERAPIEWOCHE S, P23